BlogInsights How the FDA uses real-world evidence in regulatory decisions, and what has changed since 2023
BlogInsights Prevalence of Obesity and Related Conditions and GLP-1 Use in Medicare Fee-for-Service Beneficiaries
BlogInsightsMarket Access Toward a US HTA? Examining IRA’s Emerging Role – a conversation with The Evidence Base
BlogInsightsMarket Access Download our in-depth analysis of RPR-powered payer research into how the IRA’s maximum fair prices are reshaping the market
InsightsNews & Events Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program
